Childhood Cancer Survivors Face Socioeconomic Difficulties
By Elana Gotkine HealthDay Reporter
MONDAY, April 15, 2024 -- Childhood cancer survivors face socioeconomic difficulties, according to a review published online April 15 in JAMA Pediatrics.
Márk Viktor Hernádfői, M.D., from the Centre for Translational Medicine at Semmelweis University in Budapest, Hungary, and colleagues conducted a systematic review and meta-analysis of 280 articles, reporting on 389,502 survivors to examine the socioeconomic attainment of childhood cancer survivors compared to their unaffected peers.
The researchers found that childhood cancer survivors were less likely to complete higher levels of education compared with population-based controls (odds ratio, 0.69; 95 percent confidence interval, 0.40 to 1.18), and they had higher odds of health-related unemployment (odds ratio, 2.94; 95 percent confidence interval, 1.90 to 4.57) and lower rates of marriage and parenthood (odds ratios [95 percent confidence intervals], 0.72 [0.63 to 0.84] and 0.60 [0.49 to 0.74], respectively).
"Results of this systematic review and meta-analysis suggest that childhood cancer survivors face significant long-term socioeconomic challenges, particularly in education, employment, and family formation compared with their peers," the authors write. "Establishment of a lifelong follow-up support protocol is crucially needed with a distinctive emphasis on successful social reintegration. To secure the future complete psychosocial well-being and fulfillment for the current generation of patients with childhood cancer, it is paramount to take immediate action."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States
THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...
Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening
WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...
American College of Surgeons, Oct. 19-22
The annual meeting of the American College of Surgeons was held this year from Oct. 19 to 22 in San Francisco and attracted participants from around the world, including...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.